Figure 1.

Adjusted OR for immediate therapies (A) and discharge drugs (B) received by female patients with acute ST-segment elevation myocardial infarction (reference group: male). Adjusted for age, Killip classes>2, risk factors (smoking, dyslipidemia, hypertension, diabetes) and comorbidities (Charlson weighted index ≥2) and admission year

Primary reperfusion, thrombolysis or primary percutaneous coronary intervention; ACE, angiotensin-converting enzyme; AT, angiotensin-II receptor; LMWH, low-molecular-weight heparin.